methylazoxymethanol acetate has been researched along with Brain Damage, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Featherstone, RE; Fletcher, PJ; Kapur, S; Nobrega, JN; Rizos, Z | 1 |
Beaulieu, M; Coyle, JT; Johnston, MV; Singer, H | 1 |
2 other study(ies) available for methylazoxymethanol acetate and Brain Damage, Chronic
Article | Year |
---|---|
Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
Topics: Animals; Atrophy; Brain; Brain Damage, Chronic; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Female; Learning Disabilities; Male; Methylazoxymethanol Acetate; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Rats; Reinforcement, Psychology; Schizophrenia; Teratogens | 2007 |
Development of central neurotransmitter-specified neuronal systems: implications for pediatric neuro-psychiatric disorders.
Topics: Afferent Pathways; Animals; Brain Damage, Chronic; Cats; Central Nervous System; Cerebral Cortex; Chemical Phenomena; Chemistry; Child; Child, Preschool; G(M1) Ganglioside; gamma-Aminobutyric Acid; Gangliosidoses; Humans; Mental Disorders; Methylazoxymethanol Acetate; Nerve Tissue; Nervous System Diseases; Neurons; Neurotransmitter Agents; Rats; Sympathetic Nervous System; Synapses; Tourette Syndrome | 1984 |